Centogene announces ceo to take temporary medical leave of absence – biopharmaceutical industry veteran kim stratton appointed as interim ceo

Cambridge, mass. and rostock, germany and berlin, dec. 20, 2021 (globe newswire) -- centogene n.v. (nasdaq: cntg), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced today that its chief executive officer, andrin oswald, m.d., is taking a temporary medical leave of absence for a period of at least four weeks.
CNTG Ratings Summary
CNTG Quant Ranking